Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1983 1
1984 1
1985 2
1986 3
1987 4
1988 2
1989 10
1990 28
1991 13
1992 21
1993 12
1994 13
1995 13
1996 24
1997 13
1998 18
1999 9
2000 11
2001 10
2002 13
2003 16
2004 9
2005 12
2006 7
2007 13
2008 13
2009 7
2010 12
2011 13
2012 7
2013 13
2014 7
2015 10
2016 9
2017 3
2018 3
2019 6
2020 6
2021 7
2022 3
2023 6
2024 9
2025 11
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

411 results

Results by year

Filters applied: . Clear all
Page 1
Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).
Del Casale A, Sorice S, Padovano A, Simmaco M, Ferracuti S, Lamis DA, Rapinesi C, Sani G, Girardi P, Kotzalidis GD, Pompili M. Del Casale A, et al. Curr Neuropharmacol. 2019;17(8):710-736. doi: 10.2174/1570159X16666180813155017. Curr Neuropharmacol. 2019. PMID: 30101713 Free PMC article. Review.
Better results can be obtained with a SSRI combined with cognitive behavioral therapy (CBT) or the similarly oriented exposure and response prevention (ERP). Refractory OCD could be treated with different strategies, including a switch to another SSRI or clomipramine …
Better results can be obtained with a SSRI combined with cognitive behavioral therapy (CBT) or the similarly oriented exposure and response …
Obsessive-Compulsive Disorders.
Mathews C. Mathews C. Continuum (Minneap Minn). 2021 Dec 1;27(6):1764-1784. doi: 10.1212/CON.0000000000001011. Continuum (Minneap Minn). 2021. PMID: 34881735 Review.
RECENT FINDINGS: OCD affects 2% to 3% of adults worldwide and is associated with substantial individual disability and societal costs. ...Cognitive-behavioral therapy (CBT), specifically a form of CBT that includes a type of behavioral intervention called exposure and resp …
RECENT FINDINGS: OCD affects 2% to 3% of adults worldwide and is associated with substantial individual disability and societal costs …
Pharmacological treatment of obsessive-compulsive disorder.
Pittenger C, Bloch MH. Pittenger C, et al. Psychiatr Clin North Am. 2014 Sep;37(3):375-91. doi: 10.1016/j.psc.2014.05.006. Epub 2014 Jul 24. Psychiatr Clin North Am. 2014. PMID: 25150568 Free PMC article. Review.
Obsessive-compulsive disorder (OCD) affects up to 2.5% of the population of the course of a lifetime and produces substantial morbidity. ...Proven second-line treatments include the tricyclic clomipramine and the addition of low-dose neuroleptic medications. OCD …
Obsessive-compulsive disorder (OCD) affects up to 2.5% of the population of the course of a lifetime and produces substantial morbidi …
Clomipramine.
Wilson M, Tripp J. Wilson M, et al. 2024 Aug 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. 2024 Aug 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. PMID: 31082050 Free Books & Documents.
Clomipramine is a tricyclic antidepressant (TCA) that primarily exerts therapeutic effects through potent serotonin reuptake inhibition. This medication is FDA-approved to treat obsessive-compulsive disorder (OCD) in patients aged 10 and older. Clomipramine' …
Clomipramine is a tricyclic antidepressant (TCA) that primarily exerts therapeutic effects through potent serotonin reuptake inhibiti …
Clomipramine for OCD.
Fineberg N, Baldwin D, Green M, Montgomery SA. Fineberg N, et al. Br J Psychiatry. 1990 Jun;156:908-9. doi: 10.1192/bjp.156.6.908. Br J Psychiatry. 1990. PMID: 2278561 No abstract available.
Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment.
de Oliveira MVS, de Barros PMF, de Mathis MA, Boavista R, Chacon P, Echevarria MAN, Ferrão YA, Vattimo EFQ, Lopes AC, Torres AR, Diniz JB, Fontenelle LF, Rosário MCD, Shavitt RG, Miguel EC, da Silva RMF, Costa DLDC. de Oliveira MVS, et al. Braz J Psychiatry. 2023 May 11;45(2):146-161. doi: 10.47626/1516-4446-2022-2891. Braz J Psychiatry. 2023. PMID: 36749887 Free PMC article.
OBJECTIVES: To summarize evidence-based pharmacological treatments and provide guidance on clinical interventions for adult patients with obsessive-compulsive disorder (OCD). METHODS: The American Psychiatric Association (APA) guidelines for the treatment of OCD (20 …
OBJECTIVES: To summarize evidence-based pharmacological treatments and provide guidance on clinical interventions for adult patients with ob …
Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment.
Boaden K, Tomlinson A, Cortese S, Cipriani A. Boaden K, et al. Front Psychiatry. 2020 Sep 2;11:717. doi: 10.3389/fpsyt.2020.00717. eCollection 2020. Front Psychiatry. 2020. PMID: 32982805 Free PMC article.
Our meta-review included nine systematic reviews/meta-analyses (2 on ADHD; 1 on AD; 2 on ASD; 1 on enuresis; 1 on MDD, 1 on OCD and 1 on PTSD). In terms of efficacy this review found that, compared to placebo: fluoxetine was more efficacious in the treatment of MDD, fluvox …
Our meta-review included nine systematic reviews/meta-analyses (2 on ADHD; 1 on AD; 2 on ASD; 1 on enuresis; 1 on MDD, 1 on OCD and 1 …
Treatment of Obsessive-Compulsive Disorder in Children and Youth: A Meta-Analysis.
Steele DW, Kanaan G, Caputo EL, Freeman JB, Brannan EH, Balk EM, Trikalinos TA, Adam GP. Steele DW, et al. Pediatrics. 2024 Dec 6. doi: 10.1542/peds.2024-068992. Online ahead of print. Pediatrics. 2024. PMID: 39639456
CONTEXT: Treatments for obsessive-compulsive disorder (OCD) in children and adolescents. OBJECTIVE: Evaluate the comparative efficacy of behavioral and pharmacologic treatments. ...CONCLUSIONS: ERP, delivered in-person or via telehealth, SSRIs and clomipramine are a …
CONTEXT: Treatments for obsessive-compulsive disorder (OCD) in children and adolescents. OBJECTIVE: Evaluate the comparative efficacy …
Obsessive-compulsive disorder.
Bokor G, Anderson PD. Bokor G, et al. J Pharm Pract. 2014 Apr;27(2):116-30. doi: 10.1177/0897190014521996. Epub 2014 Feb 27. J Pharm Pract. 2014. PMID: 24576790 Review.
Obsessive-compulsive disorder (OCD) is a common heterogeneous psychiatric disorder manifesting with obsessions and compulsions. ...Neurotransmitters implicated in OCD include serotonin, dopamine, and glutamate. Numerous drugs such as atypical antipsychotics and dopa …
Obsessive-compulsive disorder (OCD) is a common heterogeneous psychiatric disorder manifesting with obsessions and compulsions. ...Ne …
Pharmacotherapy for trichotillomania.
Hoffman J, Williams T, Rothbart R, Ipser JC, Fineberg N, Chamberlain SR, Stein DJ. Hoffman J, et al. Cochrane Database Syst Rev. 2021 Sep 28;9(9):CD007662. doi: 10.1002/14651858.CD007662.pub3. Cochrane Database Syst Rev. 2021. PMID: 34582562 Free PMC article.
TCAs with predominantly SRI actions versus other TCAs in adults There may be greater treatment response in the TCAs with predominantly SRI actions group compared to the other TCAs group after five weeks, based on a single trial comparing clomipramine to desipramine (mean d …
TCAs with predominantly SRI actions versus other TCAs in adults There may be greater treatment response in the TCAs with predominantly SRI a …
411 results